Neola Medical AB (publ) (STO:NEOLA)
Sweden · Delayed Price · Currency is SEK 0.8650
+0.0250 (2.98%)
Jun 15, 2026, 9:39 AM CET
Neola Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 9.96 | 16.12 | 19.56 | 21.58 | 40.09 | 22.94 |
Cash & Short-Term Investments | 9.96 | 16.12 | 19.56 | 21.58 | 40.09 | 22.94 |
Cash Growth | -69.52% | -17.55% | -9.38% | -46.17% | 74.76% | 37.80% |
Accounts Receivable | 1.16 | 1.11 | - | - | - | - |
Other Receivables | - | - | 1.07 | 20.9 | 1.02 | 1.45 |
Receivables | 1.16 | 1.11 | 1.07 | 20.9 | 1.02 | 1.45 |
Prepaid Expenses | - | - | 0.42 | 0.63 | 0.49 | 0.4 |
Other Current Assets | - | - | - | - | -0 | - |
Total Current Assets | 11.11 | 17.24 | 21.04 | 43.11 | 41.6 | 24.79 |
Property, Plant & Equipment | 0.2 | 0.22 | 0.2 | 0.14 | 0.22 | 0.16 |
Long-Term Deferred Charges | 63.84 | 61.22 | 52.37 | 42.78 | 33.51 | 18.88 |
Other Long-Term Assets | 0.15 | 0.13 | - | - | - | 0 |
Total Assets | 75.3 | 78.8 | 73.61 | 86.02 | 75.33 | 43.83 |
Accounts Payable | - | - | 1.07 | 2.18 | 1.49 | 1.3 |
Accrued Expenses | 1.72 | 1.56 | 2 | 1.62 | 1.79 | 1.44 |
Current Income Taxes Payable | - | - | 0.1 | 0.09 | 0.08 | 0.05 |
Other Current Liabilities | 1.34 | 1.44 | 1.49 | 2.27 | 1.98 | 0.41 |
Total Current Liabilities | 3.07 | 3 | 4.65 | 6.16 | 5.35 | 3.19 |
Other Long-Term Liabilities | - | - | - | 0.83 | 2.5 | - |
Total Liabilities | 3.07 | 3 | 4.65 | 6.99 | 7.85 | 3.19 |
Common Stock | 72.23 | 75.8 | 5.01 | 3.98 | 3.98 | 1.5 |
Additional Paid-In Capital | - | - | 99.08 | 80.11 | 79.56 | 44.83 |
Retained Earnings | - | - | -35.13 | -25.06 | -16.05 | -5.7 |
Comprehensive Income & Other | - | - | - | 20 | - | - |
Shareholders' Equity | 72.23 | 75.8 | 68.96 | 79.03 | 67.49 | 40.63 |
Total Liabilities & Equity | 75.3 | 78.8 | 73.61 | 86.02 | 75.33 | 43.83 |
Net Cash (Debt) | 9.96 | 16.12 | 19.56 | 21.58 | 40.09 | 22.94 |
Net Cash Growth | -69.52% | -17.55% | -9.38% | -46.17% | 74.76% | 37.80% |
Net Cash Per Share | 0.13 | 0.21 | 0.28 | 0.39 | 1.54 | 1.64 |
Filing Date Shares Outstanding | 77.95 | 77.95 | 70.15 | 70.15 | 55.69 | 21.05 |
Total Common Shares Outstanding | 77.95 | 77.95 | 70.15 | 55.69 | 55.69 | 21.05 |
Working Capital | 8.04 | 14.24 | 16.39 | 36.95 | 36.26 | 21.59 |
Book Value Per Share | 0.93 | 0.97 | 0.98 | 1.42 | 1.21 | 1.93 |
Tangible Book Value | 72.23 | 75.8 | 68.96 | 79.03 | 67.49 | 40.63 |
Tangible Book Value Per Share | 0.93 | 0.97 | 0.98 | 1.42 | 1.21 | 1.93 |
Machinery | - | - | 0.46 | 0.31 | 0.31 | 0.2 |